Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study.
暂无分享,去创建一个
V. Rohmer | P. Caron | S. Dejager | F. Borson‐Chazot | J. Orgiazzi | S. Bisot-Locard | J. Wemeau | A. Beckers | I. Bourdeix | M. Nocaudie | P. Perimenis